The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...

Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has received IND approval for two clinical ...

ATLANTA — Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, ...

Lyophilization plays a crucial role in successful biologic molecule development, but what is lyophilization – and how can it ...

Multi-drug resistant bacterial pathogens such as Mycobacterium tuberculosis are a global threat to human and animal health.

Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...

A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The ...

Zoetis enjoys enviable financial flexibility, even as leverage ticked up in 2015 to finance the purchase of Pharmaq and Abbott's animal health business. With long-term debt at roughly $6.6 billion at ...

A preliminary study showed first evidence of normalization of T3, T4, within weeks, with additional thyroid eye disease effects.